mRNA Assay Development Summit Embassy Suites by Hilton Boston at Logan Airport, Boston

Despite the exciting advancements and investments accelerating the development of mRNA therapies, there is still limited regulatory guidance. Moreover, developing standardized and sensitive assays to assess quality and stability still remains a key challenge.

The mRNA Assay Development Summit is the first and only meeting to address the specific technical challenges of analytical, bioanalytical and potency assay development, it will allow the field to develop a set of best practices to accelerate the movement of mRNA drugs through the clinic and to the patients. This meeting will showcase critical expertise and the latest assays developed by key industry players.

Join 60+ industry experts, including Moderna, Sanofi, Beam Therapeutics and more this December! Address key bottlenecks in the field and ensure your assay strategy is robust and reproducible to achieve regulatory compliance, therefore fast-tracking mRNA therapeutics and vaccines into the clinic and towards approval.